Treatment Overview
Photochemotherapy, or PUVA, is a combination of
ultraviolet A (UVA) light therapy and a psoralen
medication, which makes the skin more sensitive to the ultraviolet light. PUVA
can be an effective treatment for severe
atopic dermatitis.
Examples of psoralens include methoxsalen (Oxsoralen) and
trioxsalen (Trisoralen).
A psoralen medication is taken 1½ to 2 hours before exposure to UVA
light. This treatment is repeated 2 to 3 times a week; treatment length varies.
While the dose of medication is not increased, the amount of light can be
increased.
During photochemotherapy, you stand in a booth that contains light
tubes that give off UV light. Goggles should be worn to protect your eyes
during treatment. Men need to shield their genitals to avoid an increased risk
of genital cancer.
What To Expect After Treatment
As your skin recovers from treatment, it should be checked
frequently (at least once or twice a year) for signs of damage or skin
cancer.
Why It Is Done
PUVA is usually only used for adults with severe and hard-to-treat
cases of atopic dermatitis. It generally is not recommended for
children.
How Well It Works
PUVA is effective in managing hard-to-treat atopic
dermatitis.
Risks
Risks related to PUVA treatment include:
- Skin cancer and cancer. Exposure to UV light
may result in skin cancer. The male genitals are highly susceptible to the
cancer-causing effects of UV therapy.
- Skin damage. Exposure to UV
light may lead to sunburn and skin damage.
- Cataracts. The risk of cataracts can be reduced by
regular use of sunglasses that block UV light when
outdoors.
- Worsening of other skin diseases.
What To Think About
Because of the side effects, PUVA is not generally recommended for
children unless all other treatment fails to control severe atopic
dermatitis.
Complete the
special treatment information form (PDF)
(What is a PDF document?)
to help you understand this treatment.